Cytokine Regulation and the Signaling Mechanism of Osteoclast Inhibitory Peptide-1 (OIP-1/hSca) to Inhibit Osteoclast Formation
Open Access
- 1 March 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 18 (3), 458-465
- https://doi.org/10.1359/jbmr.2003.18.3.458
Abstract
The osteoclast (OCL) is the primary bone resorbing cell. OCL formation and activity is regulated by local factors produced in the bone microenvironment. We recently identified OCL inhibitory peptide‐...Keywords
This publication has 38 references indexed in Scilit:
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- Identification of the Functional Domain of Osteoclast Inhibitory Peptide-1/hScaJournal of Bone and Mineral Research, 2002
- Nitric oxide and boneImmunology, 2001
- Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling PathwaysPublished by Elsevier BV ,2001
- Interferon-γ Directly Inhibits TRANCE-Induced OsteoclastogenesisBiochemical and Biophysical Research Communications, 2000
- CFU-GM-Derived Cells Form Osteoclasts at a Very High EfficiencyBiochemical and Biophysical Research Communications, 2000
- Posttranslational Modification of Glycosylphosphatidylinositol (GPI)-Specific Phospholipase D and Its Activity in Cleavage of GPI AnchorsBiochemical and Biophysical Research Communications, 1998
- Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.JCI Insight, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domainCell, 1994